Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF.

This study was to examine cortical thickness in drug naïve, first episode schizophrenia patients, and to explore its relationship with serum levels of brain-derived neurotrophic factor (BDNF). Forty-five drug naive schizophrenia patients and 28 healthy controls were enrolled in the study. Freesurfer was used to parcellate cortical regions, and vertex-wise group analysis was used for whole brain cortical thickness. The clusters for the brain regions that demonstrated group differences were extracted, and the mean values of thickness were calculated. Serum levels of BDNF were measured using enzyme-linked immunosorbent assay (ELISA). After controlling for age and gender, significantly thinner cortical thickness was found in left insula and superior temporal gyrus in the patient group compared with the healthy control group (HC group) (p's < 0.001). Lower serum levels of BDNF were also found in the patient group compared with the HC group (p = 0.001). Correlation analysis showed a significant positive relationship between thickness of left insula and serum levels of BDNF within the HC group (r = 0.396, p = 0.037) but there was no such relationship within the patient group (r = 0.035, p = 0.819). Cortical thinning is present in drug naïve, first episode schizophrenia patients, indicating neurodevelopmental abnormalities at the onset of schizophrenia. Left insula might be an imaging biomarker in detecting the impaired protective role of neurotrophic factor for the brain development in schizophrenia.

[1]  J. Sato,et al.  Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia , 2013, Schizophrenia Research.

[2]  M. Stryker,et al.  Cortical Degeneration in the Absence of Neurotrophin Signaling Dendritic Retraction and Neuronal Loss after Removal of the Receptor TrkB , 2000, Neuron.

[3]  J. Kleinman,et al.  BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. , 2006, Gene expression patterns : GEP.

[4]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[5]  Eve C. Johnstone,et al.  Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison , 2013, Schizophrenia Research.

[6]  C. Lange,et al.  Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment , 2011, Journal of clinical psychopharmacology.

[7]  A. Sartorius,et al.  Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in Rats , 2009, Pharmacopsychiatry.

[8]  Marianna D. Eddy,et al.  Regionally Localized Thinning of the Cerebral Cortex in Schizophrenia , 2003 .

[9]  Peter J. Siekmeier,et al.  Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology , 2013, PloS one.

[10]  S. Zeiler,et al.  Development/Plasticity/Repair Brain-Derived Neurotrophic Factor Is Required for the Maintenance of Cortical Dendrites , 2022 .

[11]  Melissa J. Green,et al.  Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis , 2011, Molecular Psychiatry.

[12]  J. Csernansky,et al.  Longitudinal progression of frontal and temporal lobe changes in schizophrenia , 2012, Schizophrenia Research.

[13]  Vaughan J. Carr,et al.  Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia , 2012, Neuroscience & Biobehavioral Reviews.

[14]  Dennis Velakoulis,et al.  Surface‐based morphometry of the anterior cingulate cortex in first episode schizophrenia , 2008, Human brain mapping.

[15]  A. Sampson,et al.  Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia , 2005, The Journal of Neuroscience.

[16]  M. Yücel,et al.  Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies , 2009, Schizophrenia Research.

[17]  I. Liappas,et al.  A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia , 2014, PloS one.

[18]  R. Kahn,et al.  Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient , 2012, Psychological Medicine.

[19]  B. Pollock,et al.  Neuroimaging evidence for the deficit subtype of schizophrenia. , 2013, JAMA psychiatry.

[20]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[21]  William A Banks,et al.  Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.

[22]  Sven Haller,et al.  Can cortical thickness asymmetry analysis contribute to detection of at-risk mental state and first-episode psychosis? A pilot study. , 2009, Radiology.

[23]  Bruce Fischl,et al.  Geometrically Accurate Topology-Correction of Cortical Surfaces Using Nonseparating Loops , 2007, IEEE Transactions on Medical Imaging.

[24]  J. Harrison.  Orthodontic Clinical Trials III: Reporting of Ethical Issues Associated with Clinical Trials Published in Three Orthodontic Journals between 1989 and 1998 , 2005, Journal of orthodontics.

[25]  Edward J. Wild,et al.  Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease , 2011, PloS one.

[26]  E. McAuley,et al.  Brain-Derived Neurotrophic Factor Is Associated with Age-Related Decline in Hippocampal Volume , 2010, The Journal of Neuroscience.

[27]  Ron Kikinis,et al.  Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. , 2002, Archives of general psychiatry.

[28]  Jeffrey D Dawson,et al.  Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. , 2007, The American journal of psychiatry.

[29]  James J Levitt,et al.  A selective review of volumetric and morphometric imaging in schizophrenia. , 2010, Current topics in behavioral neurosciences.

[30]  J. Waller,et al.  Atypical neuroleptics stimulate neurogenesis in adult rat brain , 2002, Journal of neuroscience research.

[31]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Vázquez-Barquero,et al.  Insular cortex thinning in first episode schizophrenia patients , 2010, Psychiatry Research: Neuroimaging.

[33]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[34]  M. Shenton,et al.  Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study , 2004, Biological Psychiatry.

[35]  André J. W. van der Kouwe,et al.  Reliability of MRI-derived cortical and subcortical morphometric measures: Effects of pulse sequence, voxel geometry, and parallel imaging , 2009, NeuroImage.

[36]  N. Andreasen,et al.  Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients , 2000, Schizophrenia Research.

[37]  Peter F. Buckley,et al.  Neurotrophins and schizophrenia , 2007, Schizophrenia Research.

[38]  B. Kolachana,et al.  Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Differentially Predicts Hippocampal Function in Medication-Free Patients with Schizophrenia , 2012, Molecular Psychiatry.

[39]  M. Keshavan,et al.  Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia , 2010, Schizophrenia Research.

[40]  P. Nikolaidou,et al.  Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients , 2011, Schizophrenia Research.

[41]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[42]  K. Sim,et al.  Amygdala–hippocampal shape and cortical thickness abnormalities in first-episode schizophrenia and mania , 2012, Psychological Medicine.

[43]  A. Dale,et al.  Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.

[44]  Bai Lu,et al.  BDNF and activity-dependent synaptic modulation. , 2003, Learning & memory.

[45]  E. McAuley,et al.  Aerobic fitness is associated with hippocampal volume in elderly humans , 2009, Hippocampus.

[46]  R. Kahn,et al.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. , 2013, Schizophrenia bulletin.

[47]  J. Kleinman,et al.  Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia , 2005, Molecular Psychiatry.

[48]  N. Andreasen,et al.  Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features , 2010, Psychological Medicine.

[49]  Daniel R Weinberger,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.

[50]  T. Goldberg,et al.  Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.